← Back to catalogue

Cancer Antigen 72-4 (eCLIA)

EUDAMED

Class IVD General (EU MDR)

Ref 0320501704Model 2×100 TModel : 50T, 2×50T, 100T, 2×100T

by Shenzhen Lifotronic Technology Co., Ltd.

Identity

Trade Name
Cancer Antigen 72-4 (eCLIA) EUDAMED
Device Name
Cancer Antigen 72-4 (eCLIA) EUDAMED
Model / Reference
2×100 T EUDAMED
0320501704 EUDAMED
: 50T, 2×50T, 100T, 2×100T EUDAMED

Identifiers

Primary DI / UDI-DI
06975984063584 EUDAMED
Basic UDI-DI
B-06975984063584 EUDAMED
69703416803205052JE EUDAMED
EMDN Code
W0102030105 CANCER ANTIGEN 72-4 EUDAMED

Classification

Device Class
Class IVD General EUDAMED
Class C EUDAMED
Market of Registration
Germany EUDAMED

Clinical & Handling

Sterile

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Microbial Substances

No

EUDAMED

Reagent

Yes

EUDAMED

Self Testing

No

EUDAMED

Near-Patient Testing

No

EUDAMED

Professional Testing

Yes

EUDAMED

Companion Diagnostics

No

EUDAMED

Surgical Instrument

No

EUDAMED

New Device

No

EUDAMED

Cancer Antigen 72-4 (eCLIA) by Shenzhen Lifotronic Technology Co., Ltd. — Class IVD General — IVDR, IVDD — listed in EUDAMED — regulatory data on deviCERTS

Authorization Coverage (European Union — 27 member states)

Regulatory Authorizations

European Union Active

CE/IVDR

European Union Active

CE/IVDD

Is this your device? Claim it to add documentation and request validation.

Manufacturer

EUDAMED SRN
CN-MF-000005654
Authorised Representative
Shanghai International Holding Corp. GmbH(Europe) DE-AR-000000001

Sources (2)

  • EUDAMED 2d8c7fba-a274-4225-b006-047228723ca1 61 fields · synced Aug 3, 2026
  • EUDAMED 27ca48aa-e87d-414a-b869-69b7ead10112 61 fields · synced May 17, 2026